OR WAIT null SECS
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
First-time generic approvals: fosphenytoin for injection; pantoprazole delayed-release tablets; cefotetan for injection; cefepime for injection.
Fosphenytoin for injection, eq 50 mg/mL phenytoin (equiv to Cerebyx for injection)
ABRAXIS, APOTEX, BAXTER, BEDFORD, HOSPIRA, PHARMAFORCE, TEVA, WOCKHARDT
Pantoprazole delayed-release tablets, eq 20-and 40-mg base (equiv to Protonix delayed-release tablets)
Cefotetan for injection (equiv to Cefotan [discontinued])
ABRAXIS
Cefepime for injection, 500 mg/ vial, 1 g/vial, and 2 g/vial (equiv to Maxipime for injection)
ORCHID